Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma (R2-CHOP2)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Centre Henri Becquerel
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation
ClinicalTrials.gov Identifier:
NCT01393756
First received: July 4, 2011
Last updated: November 12, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)